Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37621515)
Watch
English
The treatment of idiopathic pulmonary fibrosis.
scientific article published on 03 March 2014
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
title
The treatment of idiopathic pulmonary fibrosis
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
main subject
pulmonary fibrosis
1 reference
based on heuristic
inferred from title
author
Toby Maher
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
author name string
Hannah V Woodcock
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
publication date
3 March 2014
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
published in
F1000prime reports
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
volume
6
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
page(s)
16
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
cites work
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Current and novel drug therapies for idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Targeting the TGFβ signalling pathway in disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Lebrikizumab treatment in adults with asthma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
The rising incidence of idiopathic pulmonary fibrosis in the U.K
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Non-steroid agents for idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Pirfenidone in idiopathic pulmonary fibrosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Pirfenidone in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Incidence and prevalence of idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
High-dose acetylcysteine in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
Q28215495
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
23 August 2017
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
6 September 2017
The big clinical trials in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
6 September 2017
Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
6 September 2017
A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
14 September 2017
Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
14 September 2017
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
14 September 2017
Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
28 September 2017
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
1 September 2018
Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3944742
retrieved
3 December 2018
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Idiopathic pulmonary fibrosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24669297
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.12703/P6-16
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
PMCID
3944742
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
PubMed ID
24669297
1 reference
stated in
Europe PubMed Central
PMCID
3944742
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24669297%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
